Longevity Research: Progress and Predictions for the Year 2030
Executive Summary
Recent years have witnessed significant strides in the field of longevity research, unveiling promising avenues for extending human healthspan. Key areas of advancement include the understanding and targeting of cellular senescence, the metabolic effects of calorie restriction, breakthroughs in regenerative medicine such as stem cell therapy and cellular reprogramming, and the therapeutic potential of gene therapy for age-related diseases. Emerging technologies like artificial intelligence (AI), big data analytics, and microphysiological systems are also playing a crucial role in accelerating discoveries and personalizing interventions. By the year 2030, it is anticipated that these research areas will converge, leading to the translation of fundamental discoveries into clinical applications capable of significantly impacting the aging process and the incidence of age-related chronic conditions. While considerable progress is expected, challenges remain in translating findings to human populations and addressing the ethical considerations associated with extending human life.
Introduction: The Quest for Extended Healthspan
The focus of aging research has increasingly shifted from merely extending lifespan to enhancing healthspan, which refers to the period of life spent in good health, free from the debilitating effects of age-related diseases 1. This emphasis reflects a growing global interest in not just living longer, but also in maintaining a high quality of life throughout the aging process 2. The increasing number of older adults worldwide underscores the societal and economic imperative to mitigate the burden of age-related chronic conditions, making the extension of healthspan a critical area of scientific inquiry 3. Longevity research is inherently multidisciplinary, drawing expertise from various fields including biology, medicine, genetics, technology, and data science, to unravel the complexities of aging and develop effective interventions. This report aims to provide an overview of the recent progress in longevity research and offer predictions for potential breakthroughs expected by the year 2030, highlighting the key areas of investigation and their anticipated impact.
3. Recent Scientific Milestones in Understanding Aging:
A deeper understanding of the fundamental biological processes underlying aging is crucial for developing targeted interventions. Several key milestones have been achieved in recent years, shedding light on the mechanisms that drive aging.
Cellular Senescence: Cellular senescence is a process where cells lose their ability to divide and replicate, accumulating with age and secreting harmful molecules that can degrade surrounding tissues and contribute to chronic inflammation 1. These senescent cells, sometimes referred to as "zombie cells," play a significant role in the development of age-related diseases 2. A major breakthrough has been the identification of senolytic drugs, such as dasatinib and quercetin, as well as fisetin, which can selectively remove these senescent cells. Studies in animal models have demonstrated that the removal of senescent cells not only extends lifespan but also significantly improves the time spent in good health 4. The consistent finding that targeting and eliminating these cells improves healthspan in animal models strongly suggests that this is a fundamental mechanism for promoting healthy aging, establishing a direct link between cellular senescence and age-related decline.
Calorie Restriction: The practice of calorie restriction, which involves reducing overall caloric intake without causing malnutrition, has long been known to extend both lifespan and healthspan in a variety of animal models 1. Recent research has begun to explore the effects of calorie restriction in humans. The Comprehensive Assessment of Long-term Effects of Reducing Intake of Energy (CALERIE) study provided compelling evidence that a modest 12% reduction in daily calorie intake in healthy adults led to improvements in several key biomarkers of aging and slowed down the pace of aging as measured by a DNA tool 1. Furthermore, the study observed a slight dose-response relationship, indicating that individuals who adhered more closely to the calorie reduction target experienced a greater slowing of their biological age 2. This suggests that interventions aimed at managing energy balance could be crucial in decelerating the human aging process. Researchers are also exploring the potential of calorie restriction mimetics, which are compounds that could mimic the beneficial effects of calorie restriction without requiring drastic dietary changes, offering a more practical approach for human application 7.
Key Biomarkers of Aging: The ability to accurately measure the rate of aging is essential for evaluating the effectiveness of longevity interventions. This has led to a significant focus on identifying reliable biomarkers of aging that can reflect an individual's biological age, which may differ from their chronological age 2. One notable discovery is InflammAge, a novel saliva-based DNA methylation biomarker that can quantify systemic chronic inflammation, a key process associated with aging 9. This non-invasive biomarker has shown a strong correlation with various health outcomes, including mortality and the risk of age-related diseases, and in some cases, it has outperformed traditional blood markers 9. Additionally, a Stanford Medicine study identified specific periods of rapid molecular change in individuals during their 40s and 60s 10. These findings suggest that there are particular stages in life where interventions might be most impactful in influencing the trajectory of aging. Ongoing efforts continue to focus on further defining and validating a panel of reliable biomarkers that can be used to track aging and the efficacy of interventions 2.
3. Breakthroughs in Regenerative Medicine for Longevity
Regenerative medicine, with its focus on repairing or replacing damaged tissues and organs, holds immense potential for combating age-related decline and extending healthspan.
Stem Cell Therapy: Stem cells are unique cells with the ability to differentiate into various specialized cell types in the body, playing a critical role in tissue repair and regeneration 7. Research is actively exploring the use of stem cells for various anti-aging applications, including the regeneration of heart tissue after damage, the improvement of muscle function in degenerative conditions, and the rejuvenation of skin cells to reduce the visible signs of aging 7. Clinical trials are underway to evaluate the effectiveness of mesenchymal stem cell interventions in addressing age-related issues such as physical frailty and facial skin aging 12. Furthermore, studies have indicated that stem cell-derived exosomes, small vesicles that facilitate intercellular communication, may have the potential to reverse skin aging 8. While stem cell therapy offers considerable promise, the variability in its effectiveness depending on the age of the stem cell donor 14 highlights the need for more research to optimize cell sources and delivery methods for achieving consistent anti-aging effects in humans. The outcomes of ongoing clinical trials will be crucial in determining the real-world impact of these therapies on the aging process.
Tissue Engineering and Organ Regeneration: Advancements in tissue engineering and organ regeneration technologies are paving the way for potential solutions to age-related organ failure. Researchers are making progress in growing ectopic organs in laboratory settings and utilizing 3D bioprinting techniques to create complex, functional tissue-like structures from living cells 15. These technologies hold the promise of creating replacement tissues and organs that could address damage caused by aging and disease. Significant research is also being conducted on developing small molecule drugs that can stimulate endogenous stem cells to repair cartilage damage in osteoarthritis, restore lung tissue function in pulmonary diseases, regenerate cardiac tissue after heart attacks, and repair retinal damage in macular degeneration 16. This approach of using drugs to activate the body's own regenerative capabilities offers a less invasive alternative to traditional cell-based therapies. The progress in regenerating various tissues and organs suggests a future where age-related organ decline might be effectively managed through these innovative therapies, leading to a substantial extension of healthspan.
Cellular Reprogramming: A groundbreaking area of research involves cellular reprogramming, a process that can revert somatic cells (any cell of a living organism other than the reproductive cells) back to an embryonic-like pluripotent state 18. This discovery demonstrated that the age of a cell is not a fixed characteristic and can potentially be reversed. In vivo reprogramming efforts in animal models, using specific factors known as Yamanaka factors, have shown remarkable promise in achieving rejuvenation effects and facilitating cell replacement in aged tissues 18. Studies have even observed epigenetic rejuvenation, a reversal of age-related changes at the molecular level, in human keratinocytes treated to express these reprogramming factors 20. Furthermore, researchers are investigating gene therapy as a means to deliver and express these reprogramming factors for the treatment of various age-related diseases. The ability to essentially turn back the clock on cellular aging through reprogramming represents a fundamental shift in our understanding of aging as a potentially reversible process. The extension of lifespan and the improvement of health parameters observed in mice through partial reprogramming provide a strong impetus for translating these exciting findings into therapeutic strategies for humans.
4. The Promise of Gene Therapy in Targeting Age-Related Diseases
Gene therapy offers a powerful approach to directly address the genetic underpinnings of aging and age-related diseases by manipulating the genetic material within cells 8.
Targeting Aging-Related Genes: Researchers have identified numerous genes that play a significant role in the aging process. Gene therapy holds the potential to target these aging-related genes, such as telomerase reverse transcriptase (TERT), APOE, KLOTHO, and FOXOs, to slow down or even reverse biological aging 21. Telomeres, protective caps at the ends of chromosomes, shorten with age, and the TERT gene encodes an enzyme that can lengthen them. Studies have explored using gene therapy to deliver the TERT gene, showing promising results in delaying cellular aging and improving function in animal models 21. The APOE gene has been linked to longevity, with certain variations increasing the risk of Alzheimer's disease while others are protective, highlighting the potential for targeted gene therapies 21. The KLOTHO gene encodes proteins involved in suppressing inflammation, a key driver of aging, and boosting its activity has shown benefits in animal studies of neurodegenerative, kidney, and cardiovascular diseases 21. While some of these genes, like TERT and APOE, have entered clinical trials for specific diseases, the broader application of gene therapy to directly target aging is an active area of ongoing research.
CRISPR-Cas Genome Editing: The CRISPR-Cas genome editing technology offers an unprecedented level of precision in modifying DNA sequences, making it a powerful tool for targeting age-related changes at the genetic level 24. Scientists are exploring the use of CRISPR-Cas to edit specific age-related genes, modulate aging pathways, and restore the vitality of aged stem cells 25. For instance, research in mice has demonstrated that using CRISPR to disrupt certain genes in neural stem cells can reactivate these cells, leading to the generation of new neurons and an improvement in brain function in old age 24. CRISPR-based tools are also being developed for epigenetic rejuvenation, allowing researchers to target and modify epigenetic marks, such as DNA methylation, which play a crucial role in regulating gene expression and can change with age 25. Furthermore, CRISPR technology can be used to reactivate the expression of the telomerase enzyme, leading to the lengthening of telomeres in senescent cells, potentially extending their lifespan and functional capacity 25. The precision offered by CRISPR-Cas technology makes it a promising strategy for developing highly effective and tailored therapies that address the fundamental genetic and epigenetic changes associated with aging.
Gene Therapy for Specific Age-Related Diseases: Gene therapy is also showing significant potential in the treatment of specific age-related diseases. For retinal diseases like age-related macular degeneration (AMD) and diabetic retinopathy (DR), gene therapy strategies are being developed to deliver therapeutic proteins, such as anti-vascular endothelial growth factor (VEGF) agents, directly to the eye, potentially reducing the need for frequent injections 26. Clinical trials are currently evaluating the safety and efficacy of gene therapies like 4D-150 and ABBV-RGX-314 for these conditions 26. Research has also demonstrated that restoring youthful levels of a specific subunit of the telomerase enzyme using gene therapy can significantly reduce the signs and symptoms of aging in preclinical models relevant to Alzheimer's disease and cancer 28. Additionally, studies in aged mice have shown that gene therapy-mediated partial reprogramming using Yamanaka factors can extend lifespan and reverse various age-related changes 20. The progress of gene therapies for age-related conditions into later-stage clinical trials indicates a significant step towards translating these innovative approaches into real-world treatments.
5. Emerging Technologies Driving Longevity Research
Several emerging technologies are playing a pivotal role in accelerating the pace of longevity research and offering new tools to understand and combat aging.
Artificial Intelligence (AI) and Machine Learning (ML): AI and ML are proving to be invaluable assets in the field of longevity research 29. These technologies excel at analyzing the vast amounts of complex biological data generated in aging studies, helping researchers to identify precise biomarkers of aging and develop sophisticated "aging clocks" that can estimate an individual's biological age and predict future health risks 29. This ability to quantify and predict aging at an individual level is crucial for personalizing prevention and treatment strategies. Furthermore, AI is significantly accelerating the process of drug discovery by efficiently screening vast libraries of compounds and identifying those that have the potential to target key drivers of aging, such as cellular damage and decreased cellular energy 29. AI systems are also being developed to ensure the accurate, reliable, and understandable evaluation of various longevity-related interventions, providing researchers with robust tools to assess their effectiveness 30. Additionally, AI is being used in innovative ways, such as predicting and improving balance in virtual reality environments designed for older adults, showcasing the diverse applications of these technologies in promoting healthy aging 31. The ability of AI and ML to analyze complex biological data, identify novel targets, and personalize interventions with high efficiency makes them indispensable tools in the ongoing quest to extend human healthspan 32.
Big Data Analytics: The field of aging research is increasingly leveraging the power of big data analytics to gain a more comprehensive understanding of the aging process and its impact on health 35. Big data, characterized by its large volume, high variety, and high velocity, allows researchers to analyze vast datasets from diverse sources, including genomic data, electronic health records, and wearable devices, to identify patterns and correlations that might not be apparent through traditional research methods 32. This approach is particularly valuable in biological and geriatric research, facilitating the identification, classification, and prediction of biomarkers related to cellular senescence and age-related diseases 35. Big data analytics is also playing a crucial role in the development of health management platforms for the elderly, enabling healthcare professionals to monitor behaviors, promote active aging, and support decision-making in public healthcare and social security systems 34. The integration of big data from various sources provides a holistic view of aging at both individual and population levels, enabling the identification of risk factors and the development of personalized interventions to promote healthy aging.
Microphysiological Systems (MPS): Microphysiological systems, also known as organoids, tissue chips, or organs-on-a-chip, represent a significant advancement in in vitro modeling for aging research 38. These three-dimensional constructs of cells or tissues can replicate the complex interactions between different organs in a much smaller space, offering a valuable platform to study human aging and age-related diseases in a more controlled and human-relevant environment compared to traditional animal models 38. The National Institute on Aging (NIA) is actively investing in MPS technology, recognizing its potential to serve as an additional testing platform for preclinical drug development in aging research 38. Notably, the NIA is collaborating with the National Center for Advancing Translational Science (NCATS) on MPS-based studies aboard the International Space Station to investigate the mechanisms of accelerated physiological and molecular changes experienced by astronauts, which closely resemble aging-related changes observed on Earth, such as muscle loss and inflammation 38. MPS offer a promising avenue for gaining deeper insights into the aging process at the tissue and organ level and for accelerating the development of targeted interventions.
6. Promising Clinical Trials and Therapeutic Interventions on the Horizon (2025-2030)
The convergence of scientific understanding and technological advancements is leading to a growing number of promising clinical trials and therapeutic interventions that are expected to yield significant results by the year 2030.
Senolytics and Senomorphics: Research on senolytics, drugs that eliminate senescent cells, is rapidly advancing into clinical testing. Early results from Phase II trials of senolytic agents, such as UBX1325, have shown statistically significant improvements in vision for patients with diabetic macular edema. Several companies, including Oisín Biotechnologies and Cleara Biotech, are actively developing various senolytic and senomorphic drugs aimed at selectively targeting and eliminating or modifying the behavior of senescent cells associated with aging and age-related diseases 19. Given the encouraging preclinical data and the positive signals from early human trials, it is anticipated that senolytic therapies could become a significant part of the longevity landscape by 2030, offering a targeted approach to improve healthspan by removing damaging senescent cells.
Cellular Reprogramming: The field of cellular reprogramming, focused on reversing cellular age, is attracting substantial investment and research interest. Companies like Life Biosciences and Retro Biosciences are making significant strides in developing gene therapy approaches to express reprogramming factors, such as Yamanaka factors, for treating age-related diseases. Preclinical studies in mice and non-human primates have shown great promise, with partial reprogramming leading to the amelioration of aging symptoms and improved recovery from disease and injury. While human clinical trials are still in the early stages of planning, the significant funding and compelling preclinical data suggest that initial trials exploring the safety and efficacy of cellular reprogramming therapies in humans might be initiated by 2030, potentially representing a revolutionary approach to reversing the aging process and regenerating damaged tissues.
Metformin and Other Drug Candidates: Metformin, a widely used drug for type 2 diabetes, is under investigation for its potential to increase lifespan and healthspan in humans through the TAME (Targeting Aging with Metformin) trial 19. This clinical trial aims to determine if metformin can target fundamental aging processes and delay the onset of age-related diseases, with the ultimate goal of establishing aging as an FDA-approved indication for future clinical trials of other potential longevity therapeutics 19. Additionally, research is ongoing to explore the benefits of other existing drugs, such as GLP-1 receptor agonists, across a range of prevalent age-related conditions 19. Anti-aging compounds like rapamycin, which has shown lifespan-extending effects in various model organisms, are also continuing to be studied 6. The repurposing of existing drugs with known safety profiles offers a potentially faster pathway to clinical application in the field of longevity.
NAD+ Boosters: Nicotinamide adenine dinucleotide (NAD+) is a crucial coenzyme involved in numerous cellular processes, and its levels decline with age. Research suggests that elevating NAD+ levels through the use of NAD+ boosters, such as nicotinamide riboside, has the potential to improve health and extend lifespan, particularly in animal models 8. While more research is needed to fully understand the effects of NAD+ boosting in humans, ongoing preclinical and early clinical studies are exploring its potential to combat age-related decline and improve various physiological functions.
Table 1: Highlighted Promising Clinical Trials in Longevity Research (2025-2030)
7. The Role of Biomarkers in Tracking and Predicting Aging
Reliable biomarkers are essential for monitoring the aging process and evaluating the effectiveness of longevity interventions. The development and validation of various aging clocks, often based on DNA methylation patterns and other omics data, continue to be a significant focus of research 2. These clocks aim to provide an accurate measure of an individual's biological age, which can be a more informative metric than chronological age when assessing the impact of interventions. Longitudinal studies, such as The Longevity Study at Harvard, are crucial for linking changes in these molecular biomarkers over time to functional health and overall well-being 41. These studies will provide valuable insights into how various biomarkers are influenced by aging and whether they can predict future health outcomes. Furthermore, AI is playing an increasingly important role in identifying and validating novel biomarkers by analyzing vast datasets and uncovering subtle patterns that may not be detectable through traditional methods 29. The continued advancement of accurate and non-invasive biomarkers is critical for the progress of longevity research, providing objective measures of biological age and the impact of interventions.
8. Challenges and Ethical Considerations in Longevity Research
Despite the significant progress in longevity research, several challenges and ethical considerations must be addressed. Translating findings from animal models to humans presents a considerable scientific hurdle due to the complexity of human physiology and the aging process. Furthermore, the research and development of longevity therapeutics often involve significant financial investments. Furthermore, extending human lifespan raises profound ethical questions regarding resource allocation, societal impact, and the very definition of aging and mortality 313, S_S66, S_S79, S_S164]. Regulatory pathways for longevity therapies are also still evolving, presenting challenges in bringing these interventions to market 42.
9. Conclusion: The Future Landscape of Longevity Research Towards 2030
Looking ahead to 2030, longevity research stands at the cusp of transformative progress. The anticipated breakthroughs in areas such as senolytics, gene therapy, and regenerative medicine hold the potential to significantly impact human healthspan and the incidence of age-related diseases. The continued advancements in understanding cellular senescence and the development of effective senolytic therapies are likely to yield clinically relevant interventions. Gene therapy, with its increasing precision and expanding applications, promises to address the genetic underpinnings of aging and specific age-related conditions. Regenerative medicine, encompassing stem cell therapy, tissue engineering, and cellular reprogramming, offers the potential to repair and rejuvenate damaged tissues and even reverse cellular aging.
Emerging technologies like AI and big data analytics will continue to play a crucial role in accelerating the pace of discovery, identifying novel biomarkers, and personalizing interventions to maximize their effectiveness. Microphysiological systems will provide increasingly sophisticated in vitro models for studying aging and testing potential therapies. The convergence of these diverse research areas, coupled with the growing global commitment to healthy aging as exemplified by the UN Decade of Healthy Ageing 44, suggests a highly promising outlook for the field.
However, it is crucial to acknowledge and address the scientific, ethical, and societal challenges that accompany the pursuit of extended healthspan. Rigorous research, careful consideration of ethical implications, and the development of equitable access frameworks will be essential to ensure that the benefits of longevity research are realized in a responsible and inclusive manner. By 2030, it is expected that longevity research will not only deepen our understanding of the aging process but also translate into tangible clinical applications that will reshape healthcare and redefine our expectations for healthy aging.
Check our posts & links below for details on other exciting titles. Sign up to the Lexicon Labs Newsletter and download your FREE EBOOK!
References
1. Ask the Expert: What Are Some Promising Advances in Aging Research? - YouTube, accessed March 16, 2025, https://www.youtube.com/watch?v=SdVUs3c4DlQ
2. 2023 Breakthroughs in longevity research - Timeline, accessed March 16, 2025, https://www.timeline.com/blog/breakthroughs-in-healthy-aging-2023-top-health-span-research
3. Regenerative Medicine in Aging: Mechanisms, Models, and Therapeutic Innovations, accessed March 16, 2025, https://www.frontiersin.org/research-topics/69552/regenerative-medicine-in-aging-mechanisms-models-and-therapeutic-innovations
4. Top Breakthroughs In Aging Research, accessed March 16, 2025, https://www.afar.org/top-breakthroughs-in-aging
5. Science Saturday: A regenerative reset for aging - Mayo Clinic News Network, accessed March 16, 2025, https://newsnetwork.mayoclinic.org/discussion/science-saturday-a-regenerative-reset-for-aging/
6. History of aging research - Center for Healthy Aging - Vice President For Research, accessed March 16, 2025, https://www.research.colostate.edu/healthyagingcenter/2022/02/21/history-of-aging-research/
7. The Future of Ageing: Breakthroughs in Longevity Science and Technology - theblood.io, accessed March 16, 2025, https://www.theblood.io/blog/the-future-of-ageing-breakthroughs-in-longevity-science-and-technology
8. Life Extension Treatments: A New Era in Anti-Aging (2024) - DVC Stem, accessed March 16, 2025, https://www.dvcstem.com/post/life-extension-treatments
9. Bayer and Hurdle Announce Breakthrough in Aging Research, accessed March 16, 2025, https://www.bayer.com/media/en-us/bayer-and-hurdle-announce-breakthrough-in-aging-research/
10. Massive biomolecular shifts occur in our 40s and 60s, Stanford Medicine researchers find, accessed March 16, 2025, https://med.stanford.edu/news/all-news/2024/08/massive-biomolecular-shifts-occur-in-our-40s-and-60s--stanford-m.html
11. Will Regenerative Medicine Stop Us From Aging? - HealthCentral, accessed March 16, 2025, https://www.healthcentral.com/news/healthy-aging/regenerative-medicine-is-changing-the-way-we-age
12. Recent clinical trials with stem cells to slow or reverse normal aging processes - PMC, accessed March 16, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC10116573/
13. Recent clinical trials with stem cells to slow or reverse normal aging processes - Frontiers, accessed March 16, 2025, https://www.frontiersin.org/journals/aging/articles/10.3389/fragi.2023.1148926/full
14. Eternal Youth: A Comprehensive Exploration of Gene, Cellular, and Pharmacological Anti-Aging Strategies - PubMed Central, accessed March 16, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC10778954/
15. Emerging Technologies and Aging Research: Bioprinting, Organ Regeneration, and Beyond, accessed March 16, 2025, https://www.afar.org/events/webinar-emerging-technologies-and-aging-research
16. Reversing the damage of age-related disease - Scripps Research, accessed March 16, 2025, https://www.scripps.edu/news-and-events/press-room/regenerative-medicine/index.html
17. Scripps Research advances breakthrough regenerative medicines to reverse aging-related diseases, accessed March 16, 2025, https://www.scripps.edu/news-and-events/press-room/2024/20241030-regenerative-medicine-overview.html
18. ELIXIR of LIFE: THWARTING AGING with REGENERATIVE REPROGRAMMING - PMC - PubMed Central, accessed March 16, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC5823281/
19. Unlocking immortality: the innovations driving human longevity, accessed March 16, 2025, https://www.mewburn.com/news-insights/unlocking-immortality-the-innovations-driving-human-longevity
20. Gene Therapy-Mediated Partial Reprogramming Extends Lifespan and Reverses Age-Related Changes in Aged Mice, accessed March 16, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC10909732/
21. Manipulating Aging through Cutting-Edge Gene Therapies - NAD.com, accessed March 16, 2025, https://www.nad.com/news/cutting-edge-gene-therapy-for-gene-manipulation-revolutionizing-aging-control
22. Gene Therapy Strategies Targeting Aging-Related Diseases - PMC - PubMed Central, accessed March 16, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC10017145/
23. (PDF) Gene Therapy Strategies Targeting Aging-Related Diseases - ResearchGate, accessed March 16, 2025, https://www.researchgate.net/publication/365465050_Gene_Therapy_Strategies_Targeting_Aging-Related_Diseases
24. This gene-editing discovery could help reverse ageing - BBC Science Focus Magazine, accessed March 16, 2025, https://www.sciencefocus.com/apple-news/crispr-brain-ageing
25. CRISPR-Cas Genome Editing For Rejuvenation Of Aging Stem Cells, accessed March 16, 2025, https://www.cellandgene.com/doc/crispr-cas-genome-editing-for-rejuvenation-of-aging-stem-cells-0001
26. Gene Therapy for Non-Hereditary Retinal Disease: Age-Related Macular Degeneration, Diabetic Retinopathy, and Beyond - MDPI, accessed March 16, 2025, https://www.mdpi.com/2073-4425/15/6/720
27. Researchers focus on regenerative treatments for age-related conditions, including AMD, accessed March 16, 2025, https://www.modernretina.com/view/researchers-focus-on-regenerative-treatments-for-age-related-conditions-including-amd
28. Longevity Breakthrough: New Treatment Reverses Multiple Hallmarks of Aging, accessed March 16, 2025, https://scitechdaily.com/longevity-breakthrough-new-treatment-reverses-multiple-hallmarks-of-aging/
29. Longevity Biotechnology: AI, Biomarkers, Geroscience ... - Aging-US, accessed March 16, 2025, https://www.aging-us.com/news-room/longevity-biotechnology-ai-biomarkers-geroscience-applications-for-healthy-aging
30. Transforming longevity research: AI paves the way for personalized treatments in aging science | ScienceDaily, accessed March 16, 2025, https://www.sciencedaily.com/releases/2025/01/250127215315.htm
31. PAID POST: Better Golden Years Ahead? The Latest Breakthroughs in Aging Science, accessed March 16, 2025, https://www.texastribune.org/paid-post/better-golden-years-ahead-the-latest-breakthroughs-in-aging-science/
32. pmc.ncbi.nlm.nih.gov, accessed March 16, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC8011704/#:~:text=Given%20the%20multitude%20of%20data,amounts%20of%20health%20system%20data.
33. Machine Learning in Aging: An Example of Developing Prediction Models for Serious Fall Injury in Older Adults - PMC, accessed March 16, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC8011704/
34. (PDF) Advancing Elderly Care through Big Data Analytics and Machine Learning for Daily Activity Characterization. - ResearchGate, accessed March 16, 2025, https://www.researchgate.net/publication/385417370_Advancing_Elderly_Care_through_Big_Data_Analytics_and_Machine_Learning_for_Daily_Activity_Characterization
35. (PDF) The Role of Big Data in Aging and Older People's Health Research: A Systematic Review and Ecological Framework - ResearchGate, accessed March 16, 2025, https://www.researchgate.net/publication/355663307_The_Role_of_Big_Data_in_Aging_and_Older_People's_Health_Research_A_Systematic_Review_and_Ecological_Framework
36. Machine Learning in Aging Research - PMC, accessed March 16, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC7329169/
37. The Role of Big Data in Aging and Older People's Health Research: A Systematic Review and Ecological Framework - MDPI, accessed March 16, 2025, https://www.mdpi.com/2071-1050/13/21/11587
38. www.nia.nih.gov, accessed March 16, 2025, https://www.nia.nih.gov/research/blog/2024/10/elevate-your-aging-research-nias-emerging-technologies-portfolio#:~:text=In%20addition%20to%20MPS%2C%20other,and%20computational%20and%20interdisciplinary%20modeling.
39. Elevate your aging research with NIA's emerging technologies ..., accessed March 16, 2025, https://www.nia.nih.gov/research/blog/2024/10/elevate-your-aging-research-nias-emerging-technologies-portfolio
40. Latest advances in aging research and drug discovery - PMC, accessed March 16, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC6914421/
41. The Longevity Study — Biomarkers of Aging Consortium, accessed March 16, 2025, https://www.agingconsortium.org/longevity-study
42. Unlocking the potential of human longevity advanced therapeutics - Strategyand.pwc.com, accessed March 16, 2025, https://www.strategyand.pwc.com/de/en/industries/pharma-life-sciences/longevity-therapeutics.html
43. Study of Aging Pioneered at Cedars-Sinai, accessed March 16, 2025, https://www.cedars-sinai.org/discoveries/study-of-aging-pioneered-at-cedars-sinai.html
44. The potential of anti-aging treatment strategies. - CAS, accessed March 16, 2025, https://www.cas.org/resources/cas-insights/aging-reimagined-exploring-potential-anti-aging-treatment
.jpg)
.jpg)
No comments:
Post a Comment